These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 3132638
1. The control of hypertension and its effect on renal function in rat remnant kidney. Eliahou HE, Cohen D, Herzog D, Shechter P, Serban I, Kapuler S, Schiby G, Gavendo S. Nephrol Dial Transplant; 1988; 3(1):38-44. PubMed ID: 3132638 [Abstract] [Full Text] [Related]
2. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. Wambach G, Breuer G, Kaufmann W. Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581 [Abstract] [Full Text] [Related]
3. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats. Jarusiripipat C, Chan L, Shapiro JI, Schrier RW. J Pharmacol Exp Ther; 1992 Jan; 260(1):243-7. PubMed ID: 1731040 [Abstract] [Full Text] [Related]
4. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators. Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719 [Abstract] [Full Text] [Related]
5. Effects of probucol in renal function and structure in rats with subtotal kidney ablation. Modi KS, Schreiner GF, Purkerson ML, Klahr S. J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828 [Abstract] [Full Text] [Related]
6. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Adams LG, Polzin DJ, Osborne CA, O'Brien TD, Hostetter TH. Lab Invest; 1994 Mar; 70(3):347-57. PubMed ID: 8145529 [Abstract] [Full Text] [Related]
7. [The effect of a low-protein diet and certain pharmaceutical agents on the course of ablation nephropathy in rats]. Heller J, Cervenka L, Hellerová S. Cas Lek Cesk; 1994 Jul 18; 133(14):429-33. PubMed ID: 8069900 [Abstract] [Full Text] [Related]
8. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 Jul 18; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
9. Comparison of converting enzyme inhibitor and calcium channel blocker in SHR with nephrotoxic serum nephritis. Ohno A, Inagaki C, Honda K, Sugino N. Nihon Jinzo Gakkai Shi; 1992 Apr 18; 34(4):405-10. PubMed ID: 1635285 [Abstract] [Full Text] [Related]
10. Comparison of nisoldipine and atenolol in the treatment of essential hypertension. Takahashi H, Fukuyama M, Yoneda S, Okabayashi H, Yoshimura M. Arzneimittelforschung; 1989 Mar 18; 39(3):379-82. PubMed ID: 2667523 [Abstract] [Full Text] [Related]
11. Effect of cyclosporine in rats with reduced renal mass. Brunner FP, Hermle M, Mihatsch MJ, Thiel G. Clin Nephrol; 1986 Mar 18; 25 Suppl 1():S148-54. PubMed ID: 3708926 [Abstract] [Full Text] [Related]
12. Treatment of hypertension in chronic kidney disease. Toto RD. Semin Nephrol; 2005 Nov 18; 25(6):435-9. PubMed ID: 16298269 [Abstract] [Full Text] [Related]
13. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H. Am J Hypertens; 2006 Dec 18; 19(12):1233-40. PubMed ID: 17161768 [Abstract] [Full Text] [Related]
14. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats. Uemasu J, Tokumoto A, Godai K, Kawasaki H, Hirayama C. Exp Clin Endocrinol; 1990 Sep 18; 96(1):97-104. PubMed ID: 2279532 [Abstract] [Full Text] [Related]
15. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet. Kanno Y, Suzuki H, Okada H, Saruta T. J Cardiovasc Pharmacol; 1994 Mar 18; 23(3):480-4. PubMed ID: 7515994 [Abstract] [Full Text] [Related]
16. Renal effects of amlodipine. Saruta T, Kanno Y, Hayashi K, Suzuki H. J Hum Hypertens; 1995 Mar 18; 9 Suppl 1():S11-6. PubMed ID: 7783108 [Abstract] [Full Text] [Related]
17. The hypotensive effect of nisoldipine in renovascular hypertensive rats. Grossman E, Rosenthal T. J Hypertens Suppl; 1986 Dec 18; 4(5):S141-4. PubMed ID: 3471895 [Abstract] [Full Text] [Related]
18. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation. Grekas D, Dioudis C, Kalevrosoglou I, Papoulidou F, Goutsaridis N, Alivanis P, Tourkantonis A. Clin Nephrol; 1995 Nov 18; 44(5):299-302. PubMed ID: 8605709 [Abstract] [Full Text] [Related]
19. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S. Clin Exp Hypertens; 2005 Nov 18; 27(2-3):129-38. PubMed ID: 15835375 [Abstract] [Full Text] [Related]
20. Renal effects of 1,4-dihydropyridines in animal models of hypertension and renal failure. Garthoff B, Hirth C, Federmann A, Kazda S, Stasch JP. J Cardiovasc Pharmacol; 1987 Nov 18; 9 Suppl 1():S8-13. PubMed ID: 2441191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]